BioAffinity Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . bioAffinity Technologies Warrant
BIAFW Stock  USD 0.22  0.02  8.21%   
BioAffinity Technologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BioAffinity Technologies' valuation are provided below:
Gross Profit
1.9 M
Profit Margin
(2.17)
Revenue
6.8 M
Quarterly Revenue Growth
(0.39)
Revenue Per Share
9.324
There are over one hundred nineteen available fundamental signals for bioAffinity Technologies Warrant, which can be analyzed over time and compared to other ratios. All traders should should validate BioAffinity Technologies' prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable.

BioAffinity Technologies Total Revenue

11.3 Million

Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 731.3 K, Interest Expense of 79.1 K or Gross Profit of 4.1 M, as well as many indicators such as Price To Sales Ratio of 1.29, Dividend Yield of 0.0 or PTB Ratio of 4.01. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.
  
Build AI portfolio with BioAffinity Stock
Check out the analysis of BioAffinity Technologies Correlation against competitors.
For more information on how to buy BioAffinity Stock please use our How to Invest in BioAffinity Technologies guide.

BioAffinity Technologies Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.3 M7.5 M2.8 M
Slightly volatile
Short and Long Term Debt Total1.3 M1.4 M4 M
Pretty Stable
Other Current Liabilities1.1 M1.6 M836.8 K
Slightly volatile
Total Current Liabilities4.7 M2.8 M5 M
Very volatile
Property Plant And Equipment Net2 M1.9 M467.5 K
Slightly volatile
Accounts Payable1.2 M1.1 M336.5 K
Slightly volatile
Cash1.2 M1.3 M1.5 M
Slightly volatile
Non Current Assets Total4.6 M4.4 M1 M
Slightly volatile
Non Currrent Assets Other15.1 K22.6 K13.7 K
Slightly volatile
Cash And Short Term Investments1.2 M1.3 M1.5 M
Slightly volatile
Net Receivables1.4 M1.3 M274.4 K
Slightly volatile
Common Stock Shares Outstanding290.3 K465 K267.8 K
Slightly volatile
Liabilities And Stockholders Equity5.3 M7.5 M2.8 M
Slightly volatile
Other Current Assets255.8 K486.4 K145.6 K
Slightly volatile
Other Stockholder Equity33 M64.6 M19.9 M
Slightly volatile
Total Liabilities6.1 M3.5 M5.7 M
Pretty Stable
Total Current Assets3.8 M3.1 M2 M
Slightly volatile
Short Term Debt593.8 K625 K3.8 M
Slightly volatile
Common Stock128.7 K122.6 K41.6 K
Slightly volatile
Long Term Debt17.3 K18.2 K49.7 K
Slightly volatile
Non Current Liabilities Total689.8 K726.1 K3.1 M
Slightly volatile
Inventory24.3 K24.8 K28.5 K
Very volatile
Property Plant And Equipment Gross2.6 M2.5 M779.5 K
Slightly volatile
Short and Long Term Debt146.8 K154.5 K7.2 M
Slightly volatile
Capital Stock128.7 K122.6 K41.6 K
Slightly volatile
Current Deferred Revenue23 K22 K31.3 K
Slightly volatile
Intangible Assets643.4 K697.6 K810.9 K
Slightly volatile

BioAffinity Technologies Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization731.3 K696.5 K160.2 K
Slightly volatile
Interest Expense79.1 K83.2 K374 K
Pretty Stable
Other Operating Expenses22.1 M21.1 M6.6 M
Slightly volatile
Research Development1.8 M2.1 M1.8 M
Pretty Stable
Cost Of Revenue7.2 M6.9 M1.3 M
Slightly volatile
Total Operating Expenses14.9 M14.2 M5.3 M
Slightly volatile
Income Tax Expense7.9 K13.4 K5.5 K
Slightly volatile
Tax Provision8.3 K13.4 K5.1 K
Slightly volatile
Interest Income19.2 K20.3 K15.6 K
Slightly volatile
Selling General Administrative12 M11.4 M3.2 M
Slightly volatile
Reconciled Depreciation731.3 K696.5 K141.2 K
Slightly volatile

BioAffinity Technologies Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Change In Working Capital196.3 K206.7 K349 K
Very volatile
Begin Period Cash Flow3.1 M3.2 M1.8 M
Slightly volatile
Depreciation731.3 K696.5 K160.2 K
Slightly volatile
End Period Cash Flow1.2 M1.3 M1.5 M
Slightly volatile
Stock Based Compensation1.2 M1.1 M435.1 K
Slightly volatile
Dividends Paid148166182
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.291.361.1 K
Slightly volatile
Days Sales Outstanding48.5251.08625
Slightly volatile
Average Payables242.7 K427.4 K224.5 K
Slightly volatile
Stock Based Compensation To Revenue0.120.105739.6171
Slightly volatile
Capex To Depreciation0.140.152.7461
Pretty Stable
Inventory Turnover20519542.3253
Slightly volatile
Days Of Inventory On Hand1.841.94811
Pretty Stable
Payables Turnover5.735.451.4207
Slightly volatile
Research And Ddevelopement To Revenue0.210.22243
Slightly volatile
Capex To Revenue0.00920.009735.0272
Slightly volatile
Cash Per Share2.342.467.2183
Pretty Stable
Days Payables Outstanding51.554.2117.6 K
Pretty Stable
Income Quality0.460.720.6706
Slightly volatile
Intangibles To Total Assets0.240.30.2756
Pretty Stable
Current Ratio0.740.780.9469
Slightly volatile
Receivables Turnover7.777.41.9094
Slightly volatile
Capex Per Share0.290.180.2443
Slightly volatile
Average Receivables388.5 K370 K97.6 K
Slightly volatile
Revenue Per Share21.8820.844.4102
Slightly volatile
Interest Debt Per Share4.314.5317.7204
Pretty Stable
Debt To Assets0.250.278.1406
Very volatile
Operating Cycle50.3653.01920
Pretty Stable
Days Of Payables Outstanding51.554.2117.6 K
Pretty Stable
Ebt Per Ebit1.971.161.3827
Slightly volatile
Quick Ratio0.730.770.9442
Slightly volatile
Net Income Per E B T0.80.90.9832
Slightly volatile
Cash Ratio0.30.320.7999
Pretty Stable
Days Of Inventory Outstanding1.841.94811
Pretty Stable
Days Of Sales Outstanding48.5251.08625
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.910.9935
Slightly volatile
Fixed Asset Turnover5.465.21.0589
Slightly volatile
Debt Ratio0.250.278.1406
Very volatile
Price Sales Ratio1.291.361.1 K
Slightly volatile
Asset Turnover1.361.290.2588
Slightly volatile
Gross Profit Margin0.580.420.7888
Slightly volatile

BioAffinity Technologies Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap8.8 M9.9 M10.8 M
Slightly volatile
Enterprise Value9.1 M10.3 M11.2 M
Slightly volatile

BioAffinity Fundamental Market Drivers

About BioAffinity Technologies Financial Statements

BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue22 K23 K
Cost Of Revenue6.9 M7.2 M
Total Revenue10.8 M11.3 M
Stock Based Compensation To Revenue 0.11  0.12 
Research And Ddevelopement To Revenue 0.22  0.21 
Capex To Revenue 0.01  0.01 
Revenue Per Share 20.84  21.88 
Ebit Per Revenue(0.86)(0.90)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY